Hodgkin lymphoma: open trials in Australia

11 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Macquarie University Hospital, Macquarie University · The Alfred Hospital, Melbourne · Linear Clinical Research Ltd, Nedlands · Scientia Clinical Research, Randwick
Registry updated 2026-11-04
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Monash Health, Clayton · Austin Health, Melbourne · Linear Clinical Research, Nedlands · Gold Coast Hospital, Southport
Registry updated 2026-11-02
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Royal Adelaide Hospital (Site 0205), Adelaide · Box Hill Hospital (Site 0202), Box Hill · Townsville University Hospital (Site 0204), Townsville
Registry updated 2026-10-29
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Heidelberg · Kogarah · Macquarie University · Nedlands
Registry updated 2026-10-14
NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Adelaide · Birtinya · Fitzroy · Nedlands · South Brisbane · Waratah
Registry updated 2026-10-13
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
Epworth Hospital, East Melbourne
Registry updated 2026-10-09
NCT06383338
A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Trial Treatment · Phase 1 · Murdoch Childrens Research Institute
Peter MacCallum Cancer Centre, Melbourne
Registry updated 2026-08-27
NCT04685616
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Trial Treatment · Phase 3 · University College, London
Royal Adelaide Hospital, Adelaide · Box Hill Hospital, Box Hill · Royal Brisbane and Women's Hospital, Brisbane · Royal Darwin Hospital, Darwin · Liverpool Hospital, Liverpool · Sunshine Hospital (Western Health), Melbourne · Royal North Shore Hospital, Saint Leonards · Concord Repatriation General Hospital, Sydney · St George Hospital, Sydney · Townsville University Hospital, Townsville
Registry updated 2026-07-08
NCT05991388
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 2/3 · University of Birmingham
Queensland Children's Hospital, Brisbane · Perth Children's Hospital, Perth · The Children's Hospital at Westmead, Sydney
Registry updated 2026-02-20
NCT05180097
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Trial Treatment · Phase 2 · Canadian Cancer Trials Group
Royal Adelaide Hospital, Adelaide · Concord Repatriation General Hospital, Concord · Austin Hospital, Heidelberg · Shoalhaven Cancer Care Centre, Nowra · Sir Charles Gairdner Hospital, Perth · Wollongong Hospital, Wollongong
Registry updated 2026-02-02
NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Trial Treatment · Phase 1 · Therapeutic Advances in Childhood Leukemia Consortium
Sydney Children's Hospital, Sydney · Children's Hospital at Westmead, Westmead
Registry updated 2024-12-06

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error